AMGN AMGEN Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: AMGN

Price (delayed)

$439.33

Market cap

$237.52B

P/E Ratio

27.09

Dividend/share

$9.94

EPS

$16.22

Enterprise value

$280.83B

?
Relative Growth: Rel. Growth: 83
Relative Strength: Rel. Strength: 79
Relative Valuation: Rel. Valuation: 49
Relative Profitability: Rel. Profitability: 95

Amgen discovers, develops, manufactures and delivers innovative medicines to fight some of the world's toughest diseases. Harnessing the best of biology and technology, Amgen reaches millions of patients with its ...

Highlights
AMGEN's equity has soared by 57% YoY and by 27% from the previous quarter
The net income has grown by 32% YoY and by 12% from the previous quarter
The P/E is 19% above the last 4 quarters average of 22.8 and 6% above the 5-year quarterly average of 25.6
Sector: Healthcare
Industry: Drug Manufacturers - General
Website: http://www.amgen.com
Peers: BMY PFE GILD ABBV

Key stats

What are the main financial stats of AMGN

AMGN stock price

How has the AMGEN stock price performed over time
Intraday
1.29%
1 week
5.81%
1 month
19.96%
1 year
48.54%
YTD
34.22%
QTD
21.32%

Financial performance

How have AMGEN's revenue and profit performed over time
Revenue
$38.1B
Gross profit
$26.48B
Operating income
$11.43B
Net income
$8.74B
Gross margin
69.5%
Net margin
23%
AMGN's operating income is up by 39% year-on-year and by 8% since the previous quarter
The net income has grown by 32% YoY and by 12% from the previous quarter
The company's operating margin rose by 28% YoY and by 6% QoQ
The net margin rose by 21% year-on-year and by 10% since the previous quarter

Price vs fundamentals

How does AMGN's price correlate with its fundamentals

Growth

What is AMGEN's growth rate over time

Valuation

What is AMGEN stock price valuation
AMGN P/E details
P/E
27.09
P/B
20.29
P/S
6.23
EV/EBIT
21.68
EV/EBITDA
15.94
EV/Sales
7.37
AMGN's EPS is up by 32% year-on-year and by 12% since the previous quarter
The P/E is 19% above the last 4 quarters average of 22.8 and 6% above the 5-year quarterly average of 25.6
AMGEN's equity has soared by 57% YoY and by 27% from the previous quarter
The stock's price to book (P/B) is 34% less than its 5-year quarterly average of 30.8 but 10% more than its last 4 quarters average of 18.4
The P/S is 30% more than the last 4 quarters average of 4.8 and 27% more than the 5-year quarterly average of 4.9
The revenue has grown by 9% year-on-year and by 2.4% since the previous quarter

Efficiency

How efficient is AMGEN business performance
AMGN's return on assets is up by 28% year-on-year and by 10% since the previous quarter
The ROIC has grown by 25% YoY and by 10% from the previous quarter
AMGN's return on sales is up by 14% year-on-year and by 8% since the previous quarter
The ROE has contracted by 9% YoY

Dividends

What is AMGN's dividend history
Dividend details
DPS
$9.94
Dividend yield
2.26%
Payout ratio
61.3%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did AMGEN financials performed over time
AMGEN's total assets is 14% more than its total liabilities
AMGN's quick ratio is up by 16% year-on-year and by 12% since the previous quarter
AMGEN's current ratio has increased by 9% from the previous quarter and by 4.6% YoY
AMGEN's equity has soared by 57% YoY and by 27% from the previous quarter
AMGN's debt to equity is down by 35% YoY and by 21% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.